Children’s asthma attacks reduced and lung function improved by Dupixent in a randomized phase 3 trial
The FINANCIAL -- A pivotal Phase 3 trial of Dupixent® (dupilumab) met its primary and all key secondary endpoints in children ...
ADVERTISEMENT
Tag: dupilumab phase 3
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
The U.S. median household income for the 2019-2023 ACS 5-year period was $78,538
-
FinCEN Warns US Banks About AI Deepfake Frauds
-
Russian Downed Azerbaijani Plane, 38 Killed, 29 Survived The Crash
-
How Technology Can Improve Productivity of Your Sales Teams
-
Aduro Clean Technologies: Revolutionizing Recycling with Hydrochemolytic Innovation
-
Amazon Pharmacy plans to expand Same-Day Delivery of medications to nearly half the US in 2025
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
